The target of this effort should be to encourage corporations to keep and create new good paying jobs in the United States, to avoid tax barriers to repatriation of offshore profits and to prevent U.S. taxation from making U.S. companies noncompetitive with their foreign rivals.
While the international tax changes made by the act may have addressed the latter two goals, it has failed at the first and presumably the most important objective, which Senator Wyden stated during a March Senate Finance Committee Hearing is a need to make sure the best research and manufacturing is done in America.
R. Tamara Konetzka, Professor of Public Health Sciences, University of Chicago
David Gifford, Chief Medical Officer, the American Health Care Association
For more information, click here.
March 18
Examining Our COVID-19 Response: An Update from Federal Officials
10:00 a.m.
Anthony Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases
David Kessler, M.D., Chief Science Officer for COVID Response at the Department of Health and Human Services
Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Rochelle Walensky, M.D., M.P.H., Director of the Centers for Disease Control and Prevention (CDC)
White House to Send Masks to Communities Hit Hard by Pandemic
HHS Office of Minority Health Holds First Meeting of COVID-19 Health Equity Task Force
Centers for Medicare and Medicaid Services to Take Action in Texas after Public Health Emergency
FDA Approves Johnson & Johnson Vaccine for Emergency Use
FDA Releases Guidance for Modifying COVID-19 Vaccines
Courts
Oral Arguments Unlikely to be Heard on Public Charge Rule
Reports
GAO Testimony Before Senate Budget Committee, Low-Income Workers: Millions of Full-time Workers in the Private Sector Rely on Federal Health Care and Food Assistance Programs
GAO-21-396T, COVID-19: Key Insights from GAO’s Oversight of the Federal Public Health Response